Cenegermin

From WikiMD.org
Jump to navigation Jump to search

Cenegermin (pronunciation: sen-eh-jer-min) is a recombinant form of human nerve growth factor. It is used in the treatment of neurotrophic keratitis, a rare degenerative disease of the cornea.

Etymology

The term "Cenegermin" is derived from the Latin words "ceno" meaning new and "germin" meaning growth, referring to its role in promoting nerve growth.

Usage

Cenegermin is used in the treatment of neurotrophic keratitis, a rare degenerative disease of the cornea. It works by promoting corneal healing, reducing the risk of corneal melting, perforation, and loss of vision.

Pharmacology

Cenegermin acts as a nerve growth factor (NGF), which is a protein necessary for the growth, maintenance, and survival of certain nerve cells. It works by binding to specific receptors on the surface of cells, triggering a series of reactions that lead to cell growth and survival.

Side Effects

Common side effects of Cenegermin include eye pain, ocular hyperemia (increased blood flow to the eye), eye inflammation, and increased lacrimation (tearing).

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski